Aspire Biopharma Inc.

NASDAQ: ASBP · Real-Time Price · USD
0.55
0.01 (2.38%)
At close: Aug 22, 2025, 3:59 PM
0.52
-4.83%
After-hours: Aug 22, 2025, 07:59 PM EDT

Aspire Biopharma Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Net Income
-1.31M -359.07K -597.12K
Depreciation & Amortization
n/a n/a n/a
Stock-Based Compensation
n/a n/a n/a
Other Working Capital
1.04M 396.07K -48.52K
Other Non-Cash Items
n/a -740.15K n/a
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
1.04M 446.11K 454.21K
Operating Cash Flow
-265.19K -653.11K -142.91K
Capital Expenditures
n/a -75.9K -4.9M
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
13.78M n/a n/a
Other Investing Acitivies
n/a 284.99M n/a
Investing Cash Flow
13.78M 284.92M -4.9M
Debt Repayment
1.71M n/a -252.91K
Common Stock Repurchased
-13.78M -284.92M n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
-13.7M n/a 4.11M
Financial Cash Flow
-11.73M -284.76M 4.85M
Net Cash Flow
-7.54K -497.26K -185.46K
Free Cash Flow
-265.19K 11.14K -5.04M